Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
Sponsor:NIMH National Institute of Mental Health
Enrolling:Male and Female Patients
Study Length:8 Weeks
Clinic Visits:10
Age Range:Between 60 and 110 years old
IRB Number:7733
U.S. Government ID:NCT03761030
Contact: Marika Chrisantopoulos: 646-774-8697 / marika.chrisanthopoulos@nyspi.columbia.edu
Additional Study Information:

In this research study, you will receive a medication called carbidopa/levodopa (Sinemet). This medication is approved by the Food and Drug Administration for the treatment of Parkinson's Disease. We are using carbidopa/levodopa off-label in this study to see whether it is capable of improving depressive symptoms as well as mental and physical slowing that occur as people age.

Do You Qualify?
Are you 60 years or older?YesNo
Are you depressed?YesNo
Have you been feeling mentally or physically slowed down?YesNo
Submit
Cancel
Investigator
Bret Rutherford, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Marika Chrisantopoulos
Email: marika.chrisanthopoulos@nyspi.columbia.edu
Phone: 646-774-8697